SeaStar Medical Holding Corp
For the period ended Sep 30, 2024. Filed Nov 13, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2024 · Filed Nov 13, 2024
ICU$1.90-3.1%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 1. Condensed Consolidated Statements of Operations (Unaudited)
Condensed Consolidated Statements of Operations
| Three Months Ended September 30, | Nine Months Ended September 30, | |||
|---|---|---|---|---|
| 2024 | 2023 | 2024 | 2023 | |
| Net revenue | $68 | $— | $68 | $— |
| Cost of goods sold | — | — | — | — |
| Gross profit | 68 | — | 68 | — |
| Operating expenses | ||||
| Research and development | 2,336 | 1,087 | 6,367 | 4,798 |
| General and administrative | 2,188 | 1,855 | 6,776 | 6,475 |
| Total operating expenses | 4,524 | 2,942 | 13,143 | 11,273 |
| Loss from operations | (4,456) | (2,942) | (13,075) | (11,273) |
| Other income (expense) | ||||
| Interest income | 58 | — | 82 | — |
| Interest expense | (272) | (224) | (497) | (882) |
| Change in fair value of convertible notes | — | (291) | (6,145) | (291) |
| Change in fair value of liability classified warrants | 192 | 1,025 | (773) | 1,784 |
| Change in fair value of forward option-prepaid forward contracts | — | — | — | (1,308) |
| Loss on extinguishment of convertible notes | — | (4,949) | — | (4,949) |
| Other income | — | 149 | — | 149 |
| Total other income (expense), net | (22) | (4,290) | (7,333) | (5,497) |
| Loss before provision for income taxes | (4,478) | (7,232) | (20,408) | (16,770) |
| Provision for income taxes | — | — | 3 | 5 |
| Net loss | $(4,478) | $(7,232) | $(20,411) | $(16,775) |
| Net loss per share of common stock, basic and diluted | $(1.10) | $(9.02) | $(6.10) | $(26.16) |
| Weighted-average shares of common stock outstanding, basic and diluted | 4,086,871 | 801,939 | 3,348,490 | 641,125 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.